Effect of Medicare Reimbursement for Care Planning on End of Life Care among Patients with Alzheimer's Disease and Related Dementias: A Quasi-Experimental Study

医疗保险报销护理计划对阿尔茨海默病和相关痴呆症患者临终护理的影响:一项准实验研究

基本信息

  • 批准号:
    10677882
  • 负责人:
  • 金额:
    $ 12.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-06-01 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Alzheimer's disease and Alzheimer's Disease-related dementias (AD/ADRD) are a leading cause of death in the U.S. More than 40% of all Medicare patients who die in a given year have AD/ADRD, and the number of deaths from AD/ADRD are fast growing. Dying individuals with AD/ADRD use more aggressive care at end of life, including burdensome transitions to the hospital and invasive procedures of questionable benefit, compared to those with no cognitive impairment. Advance care planning (ACP), the process of discussing and recording patient preferences for goals of care in the event of patient losing capacity, has been shown to decrease aggressive treatment and increase use of hospice and palliative care, in particular among AD/ADRD patients. Barriers to ACP exist, and no research has examined the causal effect of ACP on end-of-life (EOL) care among AD/ADRD patients using national data. This proposal addresses these gaps by examining two recent changes in Medicare reimbursement policy: the introduction of ACP billing codes on January 1, 2016, and the introduction of comprehensive care planning (CCP) billing codes on January 1, 2017. The CCP targets cognitively impaired patients and consists of several mandated components, including development, revision or review of an Advance Care Plan. No direct evidence exists on the effect of these two reimbursement changes on EOL care; in general or among AD/ADRD patients. This proposal will utilize Medicare claims data merged with several supplementary data sources to examine multiple physician and patient factors associated with ACP and CCP billing, and will innovatively apply two quasi-experimental study designs to separately examine the causal effect of ACP and CCP billing on EOL care spending and multiple measures of EOL care utilization commonly used as indicators for quality of EOL care, among AD/ADRD patients nationwide. Advanced statistical learning techniques will be employed to further correct bias and improve precision of causal estimates. The Specific Aims are: (1) To identify the physician and patient characteristics associated with ACP and CCP billing for AD/ADRD patients; (2) To determine the effect of ACP billing on EOL care utilization and spending among AD/ADRD patients using a Regression Discontinuity Design (RDD); (3) To determine the effect of CCP billing on EOL care utilization and spending among AD/ADRD patients using an Instrumental Variables (IV) approach. IMPACT: This project will provide rigorous and critical evidence to directly inform effective policies targeted at improving EOL care for AD/ADRD patients. Further, this K01 application will establish the applicant as one the few health economists with expertise in AD/ADRD, geriatrics and palliative care. It will prepare her to become an R01-funded independent investigator in policy evaluations that lead to improved quality of care and quality of life for the aging population, in particular AD/ADRD patients.
项目概要 阿尔茨海默病和阿尔茨海默病相关痴呆 (AD/ADRD) 是导致 在美国,在某一年死亡的所有 Medicare 患者中,超过 40% 患有 AD/ADRD,并且 因 AD/ADRD 死亡的人数正在快速增长。患有 AD/ADRD 的临终患者需要更积极的护理 在生命的尽头,包括到医院的繁重过渡和效益可疑的侵入性手术, 与没有认知障碍的人相比。预先护理计划 (ACP),讨论和 事实证明,在患者丧失能力的情况下记录患者对护理目标的偏好 减少积极治疗并增加临终关怀和姑息治疗的使用,特别是在 AD/ADRD 患者中 患者。 ACP 存在障碍,并且没有研究检验 ACP 对寿命终止 (EOL) 的因果影响 使用国家数据对 AD/ADRD 患者进行护理。该提案通过审查两个方面来解决这些差距 医疗保险报销政策的最新变化:2016 年 1 月 1 日引入 ACP 账单代码, 并于 2017 年 1 月 1 日引入综合护理计划 (CCP) 计费代码。CCP 的目标 认知障碍患者,由几个强制组成部分组成,包括开发、修订 或审查预先护理计划。没有直接证据证明这两种报销的效果 EOL 护理的变化;一般情况下或 AD/ADRD 患者中。该提案将利用医疗保险索赔数据 与多个补充数据源合并,以检查多个相关的医生和患者因素 与ACP和CCP计费,并将创新性地应用两个准实验研究设计分别 检查 ACP 和 CCP 计费对 EOL 护理支出和 EOL 护理多种措施的因果影响 在全国 AD/ADRD 患者中,利用率通常被用作 EOL 护理质量的指标。 将采用先进的统计学习技术来进一步纠正偏差并提高准确性 因果估计。具体目标是: (1) 确定相关的医生和患者特征 AD/ADRD 患者的 ACP 和 CCP 账单; (2) 确定 ACP 计费对 EOL 护理的影响 使用断点回归设计 (RDD) 在 AD/ADRD 患者中使用和支出; (3) 至 使用以下方法确定 CCP 计费对 AD/ADRD 患者 EOL 护理利用率和支出的影响 工具变量(IV)方法。影响:该项目将为以下方面提供严格而关键的证据: 直接告知旨在改善 AD/ADRD 患者临终关怀的有效政策。此外,这款K01 申请将使申请人成为为数不多的在 AD/ADRD、老年病学方面具有专业知识的健康经济学家之一 和姑息治疗。这将使她做好成为 R01 资助的政策评估独立调查员的准备 从而提高老年人群(特别是 AD/ADRD 患者)的护理质量和生活质量。

项目成果

期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Use of Medicare's New Reimbursement Codes for Cognitive Assessment and Care Planning, 2017-2018.
使用 Medicare 的新报销代码进行认知评估和护理计划,2017-2018 年。
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    13.8
  • 作者:
    Li, Jing;Andy, Caroline;Mitchell, Susan
  • 通讯作者:
    Mitchell, Susan
Management of Financial Assets by Older Adults With and Without Dementia or Other Cognitive Impairments.
患有或不患有痴呆症或其他认知障碍的老年人的金融资产管理。
  • DOI:
  • 发表时间:
    2022-09-01
  • 期刊:
  • 影响因子:
    13.8
  • 作者:
    Li, Jing;Wang, Shuqi;Nicholas, Lauren Hersch
  • 通讯作者:
    Nicholas, Lauren Hersch
Association of medicaid expansion of the Affordable Care Act with the stage at diagnosis and treatment of papillary thyroid cancer: A difference-in-differences analysis.
《平价医疗法案》医疗补助扩展与甲状腺乳头状癌诊断和治疗阶段的关联:双重差分分析。
  • DOI:
  • 发表时间:
    2021-09
  • 期刊:
  • 影响因子:
    3
  • 作者:
    Limberg, Jessica;Stefanova, Dessislava;Thiesmeyer, Jessica W;Ullmann, Timothy M;Bains, Sarina;Finnerty, Brendan M;Zarnegar, Rasa;Li, Jing;Fahey Iii, Thomas J;Beninato, Toni
  • 通讯作者:
    Beninato, Toni
Out-of-Pocket Expenses for Long-Term Care by Dementia Status and Residential Setting among US Older Adults.
美国老年人按痴呆症状况和居住环境划分的长期护理自付费用。
  • DOI:
  • 发表时间:
    2024-01
  • 期刊:
  • 影响因子:
    7.6
  • 作者:
    Li, Jing;Bancroft, Hannah;Harrison, Krista L;Fox, Julia;Tyler, Ana M;Arias, Jalayne J
  • 通讯作者:
    Arias, Jalayne J
Dementia Attributable Healthcare Utilizations in the Caribbean versus United States.
加勒比地区与美国的痴呆症归因医疗保健利用率。
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Li, Jing;Weiss, Jordan;Rajadhyaksha, Ashish;Acosta, Daisy;Harrati, Amal;Jiménez Velázquez, Ivonne Z;Liu, Mao;Guerra, Jorge J Llibre;Rodriguez, Juan de Jesús Llibre;Dow, William H
  • 通讯作者:
    Dow, William H
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jing Li其他文献

Design and analysis of a novel low-temperature solar thermal electric system with two-stage collectors and heat storage units
新型两级集热器和蓄热装置低温太阳能热电系统的设计与分析
  • DOI:
    10.1016/j.renene.2011.02.008
  • 发表时间:
  • 期刊:
  • 影响因子:
    8.7
  • 作者:
    Gang Pei;Jing Li;Jie Ji
  • 通讯作者:
    Jie Ji
A Digital Signature Scheme Based on MST3 Cryptosystems
一种基于MST3密码系统的数字签名方案

Jing Li的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jing Li', 18)}}的其他基金

AIDen: An AI-empowered detection and diagnosis system for jaw lesions using CBCT
AIDen:使用 CBCT 的人工智能驱动下颌病变检测和诊断系统
  • 批准号:
    10383494
  • 财政年份:
    2022
  • 资助金额:
    $ 12.81万
  • 项目类别:
Physiologically Based Pharmacokinetic Modeling of Drug Penetration into the Human Brain and Brain Tumors
基于生理学的药物渗透到人脑和脑肿瘤的药代动力学模型
  • 批准号:
    10459595
  • 财政年份:
    2021
  • 资助金额:
    $ 12.81万
  • 项目类别:
Physiologically Based Pharmacokinetic Modeling of Drug Penetration into the Human Brain and Brain Tumors
基于生理学的药物渗透到人脑和脑肿瘤的药代动力学模型
  • 批准号:
    10674753
  • 财政年份:
    2021
  • 资助金额:
    $ 12.81万
  • 项目类别:
Physiologically Based Pharmacokinetic Modeling of Drug Penetration into the Human Brain and Brain Tumors
基于生理学的药物渗透到人脑和脑肿瘤的药代动力学模型
  • 批准号:
    10298016
  • 财政年份:
    2021
  • 资助金额:
    $ 12.81万
  • 项目类别:
Physiologically Based Pharmacokinetic Modeling of Drug Penetration into the Human Brain and Brain Tumors
基于生理学的药物渗透到人脑和脑肿瘤的药代动力学模型
  • 批准号:
    10298016
  • 财政年份:
    2021
  • 资助金额:
    $ 12.81万
  • 项目类别:
Effect of Medicare Reimbursement for Care Planning on End of Life Care among Patients with Alzheimer's Disease and Related Dementias: A Quasi-Experimental Study
医疗保险报销护理计划对阿尔茨海默病和相关痴呆症患者临终护理的影响:一项准实验研究
  • 批准号:
    10690298
  • 财政年份:
    2020
  • 资助金额:
    $ 12.81万
  • 项目类别:
Effect of Medicare Reimbursement for Care Planning on End of Life Care among Patients with Alzheimer's Disease and Related Dementias: A Quasi-Experimental Study
医疗保险报销护理计划对阿尔茨海默病和相关痴呆症患者临终护理的影响:一项准实验研究
  • 批准号:
    10172824
  • 财政年份:
    2020
  • 资助金额:
    $ 12.81万
  • 项目类别:
Effect of Medicare Reimbursement for Care Planning on End of Life Care among Patients with Alzheimer's Disease and Related Dementias: A Quasi-Experimental Study
医疗保险报销护理计划对阿尔茨海默病和相关痴呆症患者临终护理的影响:一项准实验研究
  • 批准号:
    10408777
  • 财政年份:
    2020
  • 资助金额:
    $ 12.81万
  • 项目类别:
Impact of the Physician Payments Sunshine Act on Prescription Drug Utilization and Spending
医生支付阳光法案对处方药使用和支出的影响
  • 批准号:
    9807060
  • 财政年份:
    2019
  • 资助金额:
    $ 12.81万
  • 项目类别:
Project MISSION: Developing a multicomponent, Multilevel Implementation Strategy for Syncope OptImalCare thrOugh eNgagement
项目使命:通过参与制定晕厥优化护理的多组成部分、多层次实施策略
  • 批准号:
    9755244
  • 财政年份:
    2018
  • 资助金额:
    $ 12.81万
  • 项目类别:

相似海外基金

Home-based conservative care model for advanced kidney disease
晚期肾病的家庭保守治疗模式
  • 批准号:
    10535360
  • 财政年份:
    2023
  • 资助金额:
    $ 12.81万
  • 项目类别:
Meeting the Challenges of COVID-19 by Expanding the Reach of Palliative Care: Proactive Advance Care Planning with Videos for the Elderly and all Patients with Dementia
通过扩大姑息治疗的范围来应对 COVID-19 的挑战:为老年人和所有痴呆症患者提供视频的主动预先护理计划
  • 批准号:
    10784057
  • 财政年份:
    2023
  • 资助金额:
    $ 12.81万
  • 项目类别:
Improving patient care in severe acute brain injury: a web/mobile/tablet-based communication and decision support tool for clinicians and families in the neuro-ICU
改善严重急性脑损伤患者的护理:为神经重症监护病房的临床医生和家属提供基于网络/移动/平板电脑的通信和决策支持工具
  • 批准号:
    10589141
  • 财政年份:
    2022
  • 资助金额:
    $ 12.81万
  • 项目类别:
Parenting Intervention for Caregivers who Parent a Young Child while Caring for a Spouse with an Incurable Cancer.
针对在照顾患有无法治愈癌症的配偶时养育幼儿的护理人员的育儿干预。
  • 批准号:
    10301442
  • 财政年份:
    2021
  • 资助金额:
    $ 12.81万
  • 项目类别:
The Impact of physician and health system factors on the quality of care for persons with Alzheimer's disease and related dementias at the end of life
医生和卫生系统因素对阿尔茨海默病和相关痴呆症患者临终护理质量的影响
  • 批准号:
    10032518
  • 财政年份:
    2020
  • 资助金额:
    $ 12.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了